BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 31927006)

  • 1. N
    Zhu Z; Qian Q; Zhao X; Ma L; Chen P
    Gene; 2020 Mar; 731():144348. PubMed ID: 31927006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. m
    Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
    Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m
    Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
    Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Tsuchiya K; Yoshimura K; Iwashita Y; Inoue Y; Ohta T; Watanabe H; Yamada H; Kawase A; Tanahashi M; Ogawa H; Funai K; Shinmura K; Suda T; Sugimura H
    Cancer Gene Ther; 2022 Oct; 29(10):1355-1372. PubMed ID: 35318440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALKBH5 suppresses malignancy of hepatocellular carcinoma via m
    Chen Y; Zhao Y; Chen J; Peng C; Zhang Y; Tong R; Cheng Q; Yang B; Feng X; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2020 Aug; 19(1):123. PubMed ID: 32772918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of
    Li XC; Jin F; Wang BY; Yin XJ; Hong W; Tian FJ
    Theranostics; 2019; 9(13):3853-3865. PubMed ID: 31281518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer.
    Sun Z; Su Z; Zhou Z; Wang S; Wang Z; Tong X; Li C; Wang Y; Chen X; Lei Z; Zhang HT
    FASEB J; 2022 May; 36(5):e22283. PubMed ID: 35344216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 and ALKBH5 oppositely regulate m
    Song H; Feng X; Zhang H; Luo Y; Huang J; Lin M; Jin J; Ding X; Wu S; Huang H; Yu T; Zhang M; Hong H; Yao S; Zhao Y; Zhang Z
    Autophagy; 2019 Aug; 15(8):1419-1437. PubMed ID: 30870073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALKBH5-mediated m
    Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
    Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALKBH5 regulates paclitaxel resistance in NSCLC via inhibiting CEMIP-mediated EMT.
    Gao L; Qiao L; Li Y; Jia L; Cui W; Yang J; Wu C; Wang L
    Toxicol Appl Pharmacol; 2024 Feb; 483():116807. PubMed ID: 38199493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
    Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
    Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
    Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
    Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
    Qu J; Yan H; Hou Y; Cao W; Liu Y; Zhang E; He J; Cai Z
    J Hematol Oncol; 2022 Jan; 15(1):8. PubMed ID: 35063010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM1A promotes tumor cell invasion by silencing TIMP3 in non-small cell lung cancer cells.
    Kong L; Zhang P; Li W; Yang Y; Tian Y; Wang X; Chen S; Yang Y; Huang T; Zhao T; Tang L; Su B; Li F; Liu XS; Zhang F
    Oncotarget; 2016 May; 7(19):27959-74. PubMed ID: 27058897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. m
    Xiao D; Fang TX; Lei Y; Xiao SJ; Xia JW; Lin TY; Li YL; Zhai JX; Li XY; Huang SH; Jia JS; Tian YG; Lin XL; Cai KC; Sun Y
    Aging (Albany NY); 2021 Sep; 13(17):21497-21512. PubMed ID: 34491904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk among writers, readers, and erasers of m
    Panneerdoss S; Eedunuri VK; Yadav P; Timilsina S; Rajamanickam S; Viswanadhapalli S; Abdelfattah N; Onyeagucha BC; Cui X; Lai Z; Mohammad TA; Gupta YK; Huang TH; Huang Y; Chen Y; Rao MK
    Sci Adv; 2018 Oct; 4(10):eaar8263. PubMed ID: 30306128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m
    Zhang S; Zhao BS; Zhou A; Lin K; Zheng S; Lu Z; Chen Y; Sulman EP; Xie K; Bögler O; Majumder S; He C; Huang S
    Cancer Cell; 2017 Apr; 31(4):591-606.e6. PubMed ID: 28344040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Tang B; Yang Y; Kang M; Wang Y; Wang Y; Bi Y; He S; Shimamoto F
    Mol Cancer; 2020 Jan; 19(1):3. PubMed ID: 31906946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
    Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
    J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.